RECURSION PHARMACEUTICALS, INC.
RXRX
DELAYED 1 MONTH
14 insider filings · Latest: Jun 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 5 9:03 PM | Christopher GibsonDirector | Sale | 40,000 | $3.62 | $144.8K | 883,735(D) | View → |
| Jun 5, 2026 | Jun 5 9:02 PM | Najat KhanDirector, CEO and President | Sale | 23,588 | $3.58 | $84.5K | 2,175,796(D) | View → |
| Jun 3, 2026 | Jun 4 9:04 PM | Namandje BumpusDirector | Sale | 4,386 | $3.54 | $15.5K | 43,171(D) | View → |
| Jun 2, 2026 | Jun 4 9:04 PM | Blake BorgesonDirector | Sale | 30,000 | $3.68 | $110.4K | 6,169,863(D) | View → |
| May 22, 2026 | May 27 8:15 PM | Christopher GibsonDirector | Sale | 40,000 | $3.08 | $123.2K | 883,735(D) | View → |
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Sale | 40,000 | $3.37 | $134.8K | 926,556(D) | View → |
| May 5, 2026 | May 7 8:44 PM | Blake BorgesonDirector | Sale | 30,000 | $3.52 | $105.6K | 6,199,863(D) | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Najat KhanDirector, CEO and President | Sale | 28,298 | $3.35 | $94.7K | 2,262,085(D) | View → |
| Mar 3, 2026 | Mar 4 9:38 PM | Blake BorgesonDirector | Sale | 170,000 | $3.46 | $588.2K | 6,259,863(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | Jun 5 9:03 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,263,334(D) | View → |
| May 22, 2026 | May 27 8:15 PM | Christopher GibsonDirector | Conversion | 40,000 | — | 4,303,334(D) | View → |
| May 7, 2026 | May 8 8:59 PM | Christopher GibsonDirector | Conversion | 60,000 | — | 4,343,334(D) | View → |
| Mar 9, 2026 | Mar 11 9:41 PM | Christopher GibsonDirector | Conversion | 20,000 | — | 4,523,334(D) | View → |